10 years of interferon beta-1b (Betaferon®) therapy Ludwig KapposHans-Peter Hartung INTRODUCTION Pages: iii1 - iii2
Clinical implications of neuropathological findings in multiple sclerosis Wolfgang Brück OriginalPaper Pages: iii10 - iii14
Prognostic factors for multiple sclerosis: the importance of natural history studies George C. Ebers OriginalPaper Pages: iii15 - iii20
Genomics and proteomics: role in the management of multiple sclerosis Ludwig KapposLutz AchtnichtsRaija L. P. Lindberg OriginalPaper Pages: iii21 - iii27
Long-term experience with interferon beta-1b (Betaferon®) in multiple sclerosis Barry G. W. Arnason OriginalPaper Pages: iii28 - iii33
Aggressive multiple sclerosis—is there a role for stem cell transplantation? Eva Havrdova OriginalPaper Pages: iii34 - iii37
The importance of maintaining effective therapy in multiple sclerosis Luca DurelliMarinella Clerico OriginalPaper Pages: iii38 - iii43
